Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $370.93 million. The enterprise value is $280.09 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 17.72 million shares outstanding. The number of shares has increased by 30.94% in one year.
| Current Share Class | 17.72M |
| Shares Outstanding | 17.72M |
| Shares Change (YoY) | +30.94% |
| Shares Change (QoQ) | +100.16% |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | 47.05% |
| Float | 10.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| Forward PS | 2.93 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.37, with a Debt / Equity ratio of 0.58.
| Current Ratio | 8.37 |
| Quick Ratio | 6.60 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.20 |
Financial Efficiency
Return on equity (ROE) is -86.53% and return on invested capital (ROIC) is -20.00%.
| Return on Equity (ROE) | -86.53% |
| Return on Assets (ROA) | -17.41% |
| Return on Invested Capital (ROIC) | -20.00% |
| Return on Capital Employed (ROCE) | -33.78% |
| Revenue Per Employee | $325,630 |
| Profits Per Employee | -$321,511 |
| Employee Count | 354 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Outset Medical has paid $444,000 in taxes.
| Income Tax | 444,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.72% in the last 52 weeks. The beta is 2.14, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.14 |
| 52-Week Price Change | -65.72% |
| 50-Day Moving Average | 14.16 |
| 200-Day Moving Average | 12.17 |
| Relative Strength Index (RSI) | 70.27 |
| Average Volume (20 Days) | 280,830 |
Short Selling Information
The latest short interest is 561,827, so 3.17% of the outstanding shares have been sold short.
| Short Interest | 561,827 |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 3.17% |
| Short % of Float | 5.16% |
| Short Ratio (days to cover) | 2.66 |
Income Statement
In the last 12 months, Outset Medical had revenue of $115.27 million and -$113.82 million in losses. Loss per share was -$26.02.
| Revenue | 115.27M |
| Gross Profit | 41.69M |
| Operating Income | -90.19M |
| Pretax Income | -158.67M |
| Net Income | -113.82M |
| EBITDA | -84.63M |
| EBIT | -90.19M |
| Loss Per Share | -$26.02 |
Full Income StatementBalance Sheet
The company has $189.00 million in cash and $98.17 million in debt, giving a net cash position of $90.83 million or $5.13 per share.
| Cash & Cash Equivalents | 189.00M |
| Total Debt | 98.17M |
| Net Cash | 90.83M |
| Net Cash Per Share | $5.13 |
| Equity (Book Value) | 169.87M |
| Book Value Per Share | 9.37 |
| Working Capital | 252.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$96.05 million and capital expenditures -$681,000, giving a free cash flow of -$96.74 million.
| Operating Cash Flow | -96.05M |
| Capital Expenditures | -681,000 |
| Free Cash Flow | -96.74M |
| FCF Per Share | -$5.46 |
Full Cash Flow StatementMargins
Gross margin is 36.16%, with operating and profit margins of -78.24% and -98.74%.
| Gross Margin | 36.16% |
| Operating Margin | -78.24% |
| Pretax Margin | -98.35% |
| Profit Margin | -98.74% |
| EBITDA Margin | -73.41% |
| EBIT Margin | -78.24% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.94% |
| Shareholder Yield | -30.94% |
| Earnings Yield | -30.68% |
| FCF Yield | -26.08% |
Analyst Forecast
The average price target for Outset Medical is $33.00, which is 57.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.00 |
| Price Target Difference | 57.67% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 13.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
Outset Medical has an Altman Z-Score of -4.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.33 |
| Piotroski F-Score | 5 |